Price T Rowe Associates Inc Pulse Biosciences, Inc. Transaction History

Price T Rowe Associates Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.69 - $14.54 $5,204 - $11,312	778 Added 7.77%	10,787 $121,000
Q1 2024 May 15, 2024	BUY	$7.8 - $11.02 $78,070 - $110,299	10,009 New	10,009 $88,000
Q2 2022 Aug 15, 2022	BUY	$1.48 - $4.28 $4,373 - $12,647	2,955 Added 20.18%	17,600 $27,000
Q1 2022 May 16, 2022	BUY	$4.21 - $14.79 $8,420 - $29,580	2,000 Added 15.82%	14,645 $71,000
Q4 2021 Feb 14, 2022	BUY	$14.78 - $24.4 $32,516 - $53,680	2,200 Added 21.06%	12,645 $187,000
Q3 2021 Nov 15, 2021	SELL	$17.25 - $26.63 $34,500 - $53,260	-2,000 Reduced 16.07%	10,445 $226,000
Q2 2021 Aug 16, 2021	SELL	$16.31 - $23.64 $33,190 - $48,107	-2,035 Reduced 14.05%	12,445 $204,000
Q1 2021 May 17, 2021	SELL	$22.43 - $44.27 $78,662 - $155,254	-3,507 Reduced 19.5%	14,480 $343,000
Q4 2020 Feb 16, 2021	BUY	$11.66 - $24.5 $209,728 - $440,681	17,987 New	17,987 $429,000

5.39M

139K

84.2K

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $672M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.